CLINICAL_TRIALS trial_result · 2012-01-23

Clinical Trial Update: Study of INT 747 in Combination With URSO in Patients With Primay Biliary Cirrhosis (PBC) [Phase 2]

Phase 2 trial of INT 747 in combination with URSO for primary biliary cirrhosis was terminated; results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Intercept Pharmaceuticals | Conditions: Liver Cirrhosis, Biliary | Phase 2 | Status: TERMINATED | Results posted: 2012-01-23